Poseida Announces Initial Phase 1 Data for P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed … – GlobeNewswire (press release)
Pharmaceuticals NewsPoseida Announces Initial Phase 1 Data for P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed …GlobeNewswire (press release)SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a Sa… Continue reading
